Muhammad Hasnat
Impact in
- Biomaterials top 5%
- Nanocomposite Films for Food Packaging
- Nanoparticle-Based Drug Delivery
- Supramolecular Self-Assembly in Materials
-
- Natural Compounds in Disease Treatment
Papers in
-
- RNA Interference and Gene Delivery 3
- Cell death mechanisms and regulation 3
- Advanced biosensing and bioanalysis techniques 2
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Muhammad Naveed (6 shared papers)Mirza Muhammad Faran Ashraf Baig (7 shared papers)Muhammad Sohail (4 shared papers)Luyong Zhang (8 shared papers)Zhenzhou Jiang (8 shared papers)Ziqiao Yuan (9 shared papers)Muzzamal Hussain (1 shared paper)Qi‐Gang Zhou (1 shared paper)
- Journals
- Frontiers in Pharmacology (3 papers)Food Bioscience (1 paper)British Journal of Cancer (1 paper)Journal of Food and Drug Analysis (1 paper)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaPakistanNew Zealand
In The Last Decade
Muhammad Hasnat
24 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Biomaterials 321
- Complementary and alternative medicine 160
- Molecular Medicine 62
- Pharmaceutical Science 71
- Pharmacology 81
Countries citing papers authored by Muhammad Hasnat
This map shows the geographic impact of Muhammad Hasnat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Hasnat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Hasnat more than expected).
Fields of papers citing papers by Muhammad Hasnat
This network shows the impact of papers produced by Muhammad Hasnat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Hasnat. The network helps show where Muhammad Hasnat may publish in the future.
Co-authors
The 25 scholars most cited alongside Muhammad Hasnat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chitosan oligosaccharide (COS): An overview Hit paper breakdown → | 2019 | 386 |
| 2 | 2019 | 163 | |
| 3 | 2018 | 84 | |
| 4 | 2019 | 48 | |
| 5 | 2022 | 47 | |
| 6 | 2019 | 45 | |
| 7 | 2019 | 43 | |
| 8 | 2020 | 35 | |
| 9 | 2019 | 25 | |
| 10 | 2023 | 23 | |
| 11 | 2019 | 22 | |
| 12 | 2018 | 18 | |
| 13 | 2019 | 14 | |
| 14 | 2022 | 13 | |
| 15 | 2023 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2021 | 11 | |
| 18 | 2019 | 9 | |
| 19 | 2022 | 6 | |
| 20 | 2022 | 5 |
About Muhammad Hasnat
Muhammad Hasnat is a scholar working on Molecular Biology, Biomaterials, Complementary and alternative medicine, Surgery and Pharmaceutical Science, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Natural Compounds in Disease Treatment (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Nanoplatforms for cancer theranostics (3 papers), RNA Interference and Gene Delivery (3 papers), Cell death mechanisms and regulation (3 papers), Advanced Drug Delivery Systems (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Biomaterials (321 citations), Complementary and alternative medicine (160 citations), Molecular Medicine (62 citations), Pharmaceutical Science (71 citations) and Pharmacology (81 citations). Muhammad Hasnat has collaborated with scholars based in China, Pakistan and New Zealand. Frequent co-authors include Muhammad Naveed, Mirza Muhammad Faran Ashraf Baig, Muhammad Sohail, Luyong Zhang, Zhenzhou Jiang, Ziqiao Yuan, Muzzamal Hussain, Qi‐Gang Zhou, Awais Ullah Ihsan and Mohib Ullah Kakar. Their work appears in journals such as Frontiers in Pharmacology, Food Bioscience, British Journal of Cancer, Journal of Food and Drug Analysis and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.